2017 EACTS Guidelines on perioperative medication in adult cardiac surgery. (Q50065204)

24 February 2018

title

2017 EACTS Guidelines on perioperative medication in adult cardiac surgery. (English)

1 reference

24 February 2018

Giovanni Landoni

5

0 references

Ulf Landmesser

13

object named as

Ulf Landmesser

1 reference

24 February 2018

8

Tómas Gudbjartsson

1 reference

24 February 2018

Anders Jeppsson

12

object named as

Anders Jeppsson

1 reference

24 February 2018

Jean-Philippe Collet

4

object named as

Jean-Philippe Collet

1 reference

24 February 2018

author name string

Miguel Sousa-Uva

1

1 reference

24 February 2018

Stuart J Head

2

1 reference

24 February 2018

Milan Milojevic

3

1 reference

24 February 2018

Manuel Castella

6

1 reference

24 February 2018

Joel Dunning

7

1 reference

24 February 2018

Nick J Linker

9

1 reference

24 February 2018

Elena Sandoval

10

1 reference

24 February 2018

Matthias Thielmann

11

1 reference

24 February 2018

publication date

6 October 2017

1 reference

24 February 2018

European Journal of Cardio-Thoracic Surgery

published in

1 reference

24 February 2018

volume

53

1 reference

24 February 2018

page(s)

5-33

1 reference

24 February 2018

issue

1

1 reference

24 February 2018

Full prescription coverage versus usual prescription coverage after coronary artery bypass graft surgery: analysis from the post-myocardial infarction free Rx event and economic evaluation (FREEE) randomized trial

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Efficacy of Long-Term β-Blocker Therapy for Secondary Prevention of Long-Term Outcomes After Coronary Artery Bypass Grafting Surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Causes of Death Following PCI Versus CABG in Complex CAD: 5-Year Follow-Up of SYNTAX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Use of medications for secondary prevention after coronary bypass surgery compared with percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

The benefit of adding ezetimibe to statin therapy in patients with prior coronary artery bypass graft surgery and acute coronary syndrome in the IMPROVE-IT trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contri

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Is There a Role for Cardiac Rehabilitation After Coronary Artery Bypass Grafting? Treatment After Coronary Artery Bypass Surgery Remains Incomplete Without Rehabilitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Trial of everolimus-eluting stents or bypass surgery for coronary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Optimal medical therapy improves clinical outcomes in patients undergoing revascularization with percutaneous coronary intervention or coronary artery bypass grafting: insights from the Synergy Between Percutaneous Coronary Intervention with TAXUS a

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Influence of practice patterns on outcome among countries enrolled in the SYNTAX trial: 5-year results between percutaneous coronary intervention and coronary artery bypass grafting†.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Guideline on antiplatelet and anticoagulation management in cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

The Society of Thoracic Surgeons practice guideline series: Blood glucose management during adult cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Secondary prevention after coronary artery bypass graft surgery: a scientific statement from the American Heart Association.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribut

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevati

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Aspirin and coronary artery surgery: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Stopping vs. Continuing Aspirin before Coronary Artery Surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Prediction of the excessive perioperative bleeding in patients undergoing coronary artery bypass grafting: role of aspirin and platelet glycoprotein IIIa polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

The effect of pre-operative aspirin on bleeding, transfusion, myocardial infarction, and mortality in coronary artery bypass surgery: a systematic review of randomized and observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Effect of Preoperative Aspirin Replacement With Enoxaparin in Patients Undergoing Primary Isolated On-Pump Coronary Artery Bypass Grafting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Effects of ex vivo platelet supplementation on platelet aggregability in blood samples from patients treated with acetylsalicylic acid, clopidogrel, or ticagrelor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

The effectiveness of platelet supplementation for the reversal of ticagrelor-induced inhibition of platelet aggregation: An in-vitro study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Platelet function recovery after cessation of aspirin: preliminary study of volunteers and surgical patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Aspirin and mortality from coronary bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Does aspirin 6 h after coronary artery bypass grafting optimise graft patency?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Prasugrel versus clopidogrel in patients with acute coronary syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Mortality benefit with prasugrel in the TRITON-TIMI 38 coronary artery bypass grafting cohort: risk-adjusted retrospective data analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Coronary artery bypass grafting-related bleeding complications in patients treated with ticagrelor or clopidogrel: a nationwide study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Coronary artery bypass grafting-related bleeding complications in patients treated with dual antiplatelet treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Clopidogrel-associated bleeding and related complications in patients undergoing coronary artery bypass grafting

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Current status of data on cangrelor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

P2Y(12) inhibitors: differences in properties and mechanisms of action and potential consequences for clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Safety of Preoperative Use of Ticagrelor With or Without Aspirin Compared With Aspirin Alone in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Grafting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Preoperative platelet function predicts perioperative bleeding complications in ticagrelor-treated cardiac surgery patients: a prospective observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Platelet function monitoring to adjust antiplatelet therapy in elderly patients stented for an acute coronary syndrome (ANTARCTIC): an open-label, blinded-endpoint, randomised controlled superiority trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Clopidogrel responsiveness regardless of the discontinuation date predicts increased blood loss and transfusion requirement after off-pump coronary artery bypass graft surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Multiple electrode whole-blood aggregometry and bleeding in cardiac surgery patients receiving thienopyridines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Effect of preoperative P2Y12 and thrombin platelet receptor inhibition on bleeding after cardiac surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Does Platelet Reactivity Predict Bleeding in Patients Needing Urgent Coronary Artery Bypass Grafting During Dual Antiplatelet Therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Platelet function measurement-based strategy to reduce bleeding and waiting time in clopidogrel-treated patients undergoing coronary artery bypass graft surgery: the timing based on platelet function strategy to reduce clopidogrel-associated bleedin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Should dual antiplatelet therapy be used in patients following coronary artery bypass surgery? A meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Dual anti-platelet therapy after coronary artery bypass grafting: is there any benefit? A systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Dual Antiplatelet Therapy Versus Aspirin Monotherapy in Diabetics With Multivessel Disease Undergoing CABG: FREEDOM Insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Urgent surgery in patients with a recently implanted coronary drug-eluting stent: a phase II study of 'bridging' antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials ∗ ∗A complete list of the principal investigators and study coordinators of the EPILOG (Evaluation in PTCA to Improve Long-term Outcome with abciximab GP

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Emergency coronary artery bypass grafting in patients with acute myocardial infarction treated with glycoprotein IIb/IIIa receptor inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Pacemaker or defibrillator surgery without interruption of anticoagulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Updates in the perioperative and emergency management of non-vitamin K antagonist oral anticoagulants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Fondaparinux: an effective bridging strategy in heparin-induced thrombocytopenia and mechanical circulatory support

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Brief communication: Preoperative anticoagulant activity after bridging low-molecular-weight heparin for temporary interruption of warfarin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP) - March 2013.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Direct oral anticoagulants: new drugs and new concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Reversing the new oral anticoagulants with prothrombin complex concentrates (PCCs): what is the evidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Idarucizumab for Dabigatran Reversal

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Perioperative bridging therapy with unfractionated heparin or low-molecular-weight heparin in patients with mechanical prosthetic heart valves on long-term oral anticoagulants (from the REGIMEN Registry).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Combined aspirin-oral anticoagulant therapy compared with oral anticoagulant therapy alone among patients at risk for cardiovascular disease: a meta-analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Experience with enoxaparin in patients with mechanical heart valves who must withhold acenocumarol

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Low-molecular-weight heparin as a bridging anticoagulant early after mechanical heart valve replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

The optimal management of anti-thrombotic therapy after valve replacement: certainties and uncertainties

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Warfarin treatment quality and prognosis in patients with mechanical heart valve prosthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Dabigatran versus warfarin in patients with mechanical heart valves

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Antithrombotic therapy after bioprosthetic aortic valve implantation: Warfarin versus aspirin, a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Possible Subclinical Leaflet Thrombosis in Bioprosthetic Aortic Valves.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Warfarin and Antiplatelet Therapy Versus Warfarin Alone for Treating Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Management of postoperative atrial fibrillation and subsequent outcomes in contemporary patients undergoing cardiac surgery: insights from the Society of Thoracic Surgeons CAPS-Care Atrial Fibrillation Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Atrial fibrillation after isolated coronary surgery affects late survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Postoperative atrial fibrillation in patients undergoing aortocoronary bypass surgery carries an eightfold risk of future atrial fibrillation and a doubled cardiovascular mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Guidelines on the prevention and management of de novo atrial fibrillation after cardiac and thoracic surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Timing and route of amiodarone for prevention of postoperative atrial fibrillation after cardiac surgery: a network regression meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Does treatment with n-3 polyunsaturated fatty acids prevent atrial fibrillation after open heart surgery?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Effects of magnesium on atrial fibrillation after cardiac surgery: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Pharmacological conversion of recent-onset atrial fibrillation: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Vernakalant hydrochloride for the rapid conversion of atrial fibrillation after cardiac surgery: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Rate Control versus Rhythm Control for Atrial Fibrillation after Cardiac Surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Digoxin-associated mortality: a systematic review and meta-analysis of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Perioperative atrial fibrillation and the long-term risk of ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Anticoagulation strategies for the management of postoperative atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Edoxaban versus warfarin in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Apixaban in Patients With Atrial Fibrillation After Transfemoral Aortic Valve Replacement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Preoperative β-blocker use in coronary artery bypass grafting surgery: national database analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Double-blind, placebo-controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: the beta-Blocker Length Of Stay (BLOS) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Prophylactic Oral Amiodarone for the Prevention of Arrhythmias that Begin Early After Revascularization, Valve Replacement, or Repair: PAPABEAR: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Rate-control versus conversion strategy in postoperative atrial fibrillation: trial design and pilot study results

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

The RACE study in perspective of randomized studies on management of persistent atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Patterns of management of atrial fibrillation complicating coronary artery bypass grafting: Results from the PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT-IV) Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Impact of the CHA2DS2-VASc score on anticoagulation recommendations for atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Renin-angiotensin system blockers in cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Effects of angiotensin-converting enzyme inhibition in low-risk patients early after coronary artery bypass surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Effect of preoperative angiotensin-converting enzyme inhibitor on the outcome of coronary artery bypass graft surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Low systemic vascular resistance after cardiopulmonary bypass: incidence, etiology, and clinical importance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Effects of quinapril on clinical outcome after coronary artery bypass grafting (The QUO VADIS Study). QUinapril on Vascular Ace and Determinants of Ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Preoperative use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers is associated with increased risk for acute kidney injury after cardiovascular surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

A meta-analysis reporting effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients without heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Eplerenone in patients with systolic heart failure and mild symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Combining neuroendocrine inhibitors in heart failure: reflections on safety and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Mineralocorticoid receptor antagonists in patients with heart failure: current experience and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Angiotensin-neprilysin inhibition versus enalapril in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Effect of beta-blocker use on outcomes after discharge in patients who underwent cardiac surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Effect of preoperative beta-blockade on perioperative mortality in coronary surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Perioperative beta-blocker and statin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Metoprolol treatment for two years after coronary bypass grafting: effects on exercise capacity and signs of myocardial ischaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

β-blocker Therapy is Not Associated with Reductions in Angina or Cardiovascular Events After Coronary Artery Bypass Graft Surgery: Insights from the IMAGINE Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Beta-blockers in congestive heart failure. A Bayesian meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Benefits of β blockers in patients with heart failure and reduced ejection fraction: network meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Perioperative Rosuvastatin in Cardiac Surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

High-Dose Perioperative Atorvastatin and Acute Kidney Injury Following Cardiac Surgery: A Randomized Clinical Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Intensive lipid-lowering with atorvastatin for secondary prevention in patients after coronary artery bypass surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Efficacy and safety of alirocumab in reducing lipids and cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

The impact of proprotein convertase subtilisin-kexin type 9 serine protease inhibitors on lipid levels and outcomes in patients with primary hypercholesterolaemia: a network meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Effects of combination lipid therapy in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Lipid-lowering efficacy of the PCSK9 inhibitor evolocumab (AMG 145) in patients with type 2 diabetes: a meta-analysis of individual patient data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia: A Systematic Review and Meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Predictors and outcome of gastrointestinal complications in patients undergoing cardiac surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Is routine stress ulcer prophylaxis of benefit for patients undergoing cardiac surgery?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Prospective randomized trial for optimal prophylactic treatment of the upper gastrointestinal complications after open heart surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

What is the optimum prophylaxis against gastrointestinal haemorrhage for patients undergoing adult cardiac surgery: histamine receptor antagonists, or proton-pump inhibitors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

The systemic inflammatory response syndrome and cardiopulmonary bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Clinical benefit of steroid use in patients undergoing cardiopulmonary bypass: a meta-analysis of randomized trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Methylprednisolone in patients undergoing cardiopulmonary bypass (SIRS): a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Intraoperative high-dose dexamethasone for cardiac surgery: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Perioperative Steroid Management: Approaches Based on Current Evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Management practices and major infections after cardiac surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Gentamicin-collagen sponge reduces the risk of sternal wound infections after heart surgery: Meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Antibiotic pharmacodynamics in surgical prophylaxis: an association between intraoperative antibiotic concentrations and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Adjustment of dosing of antimicrobial agents for bodyweight in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Antimicrobial dosing considerations in obese adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Comparative study of single-dose and 24-hour multiple-dose antibiotic prophylaxis for cardiac surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Does duration of perioperative antibiotic prophylaxis matter in cardiac surgery? A systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Use of antimicrobial prophylaxis for major surgery: baseline results from the National Surgical Infection Prevention Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Effect of extended perioperative antibiotic prophylaxis on intravascular catheter colonization and infection in cardiothoracic surgery patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Continuous Intraoperative Cefazolin Infusion May Reduce Surgical Site Infections During Cardiac Surgical Procedures: A Propensity-Matched Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Pharmacokinetic characteristics and microbiologic appropriateness of cefazolin for perioperative antibiotic prophylaxis in elective cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Sternal wound infections following open heart surgery - a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

New WHO recommendations on preoperative measures for surgical site infection prevention: an evidence-based global perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Preventing surgical-site infections in nasal carriers of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Prospective randomised comparison of single-dose versus multiple-dose cefuroxime for prophylaxis in coronary artery bypass grafting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Antibiotic prophylaxis in cardiac surgery: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Glycopeptides are no more effective than beta-lactam agents for prevention of surgical site infection after cardiac surgery: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Antibiotic selection in the penicillin-allergic patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Penetration of vancomycin in uninfected sternal bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Vancomycin versus cefazolin prophylaxis for cardiac surgery in the setting of a high prevalence of methicillin-resistant staphylococcal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Impact of a clinical guideline for prescribing antibiotics to inpatients reporting penicillin or cephalosporin allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Health care use and serious infection prevalence associated with penicillin "allergy" in hospitalized patients: A cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Strategies to prevent surgical site infections in acute care hospitals: 2014 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Methicillin-resistant Staphylococcus species in a cardiac surgical intensive care unit: a 5-year experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Impact of vancomycin surgical antibiotic prophylaxis on the development of methicillin-sensitive staphylococcus aureus surgical site infections: report from Australian Surveillance Data (VICNISS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Timing of antimicrobial prophylaxis and the risk of surgical site infections: results from the Trial to Reduce Antimicrobial Prophylaxis Errors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

The timing of surgical antimicrobial prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Is single-dose antibiotic prophylaxis sufficient for coronary artery bypass surgery? An analysis of peri- and postoperative serum cefuroxime and vancomycin levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Prospective randomized study of efficacy of 1-day versus 3-day antibiotic prophylaxis for preventing surgical site infection after coronary artery bypass graft

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Intraoperative redosing of cefazolin and risk for surgical site infection in cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Vancomycin sequestration during cardiopulmonary bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Serum levels of prophylactic cefazolin during cardiopulmonary bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Effects of Volatile Anesthetics on Mortality and Postoperative Pulmonary and Other Complications in Patients Undergoing Surgery: A Systematic Review and Meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Anaesthetic drugs and survival: a Bayesian network meta-analysis of randomized trials in cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Benefits and risks of epidural analgesia in cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

The effect of isoflurane on survival and myocardial infarction: a meta-analysis of randomized controlled studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Volatile anesthetics reduce mortality in cardiac surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

A comparison of volatile and non volatile agents for cardioprotection during on-pump coronary surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

The influence of propofol versus sevoflurane anesthesia on outcome in 10,535 cardiac surgical procedures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Desflurane and sevoflurane in cardiac surgery: a meta-analysis of randomized clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Sevoflurane Versus Total Intravenous Anesthesia for Isolated Coronary Artery Bypass Surgery With Cardiopulmonary Bypass: A Randomized Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Poststernotomy pain: a clinical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Management of pain in cardiac surgery ICU patients: have we improved over time?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Exposure to high stress in the intensive care unit may have negative effects on health-related quality-of-life outcomes after cardiac surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Management of Postoperative Pain: A Clinical Practice Guideline From the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists' Committee on Regional Anesthesia, Executive

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Spinal analgesia in cardiac surgery: a meta-analysis of randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Adjuvant therapy with intrathecal clonidine improves postoperative pain in patients undergoing coronary artery bypass graft

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Fast-track coronary artery bypass grafting surgery under general anesthesia with remifentanil and spinal analgesia with morphine and clonidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Use of a Continuous Local Anesthetic Infusion for Pain Management after Median Sternotomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Parasternal block and local anesthetic infiltration with levobupivacaine after cardiac surgery with desflurane: the effect on postoperative pain, pulmonary function, and tracheal extubation times

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Major complications of central neuraxial block: report on the Third National Audit Project of the Royal College of Anaesthetists

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Efficacy of adding clonidine to intrathecal morphine in acute postoperative pain: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Bilateral paravertebral blockade for conventional cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

The analgesic efficacy of continuous presternal bupivacaine infusion through a single catheter after cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

A prospective, randomized, blinded study of continuous ropivacaine infusion in the median sternotomy incision following cardiac surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Infiltration of the sternotomy wound and the mediastinal tube sites with 0.25% levobupivacaine as adjunctive treatment for postoperative pain after cardiac surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Patient-controlled versus nurse-controlled analgesia after cardiac surgery--a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Remifentanil in cardiac surgery: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Patient-controlled analgesia after coronary bypass: Remifentanil or sufentanil?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

The efficacy of intravenous patient-controlled remifentanil versus morphine anesthesia after coronary artery surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Intravenous acetaminophen analgesia after cardiac surgery: A randomized, blinded, controlled superiority trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Intravenous Acetaminophen as an Adjunct Analgesic in Cardiac Surgery Reduces Opioid Consumption But Not Opioid-Related Adverse Effects: A Randomized Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Intravenous paracetamol as adjunctive treatment for postoperative pain after cardiac surgery: a double blind randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Non-steroidal anti-inflammatory drug administration after coronary artery bypass surgery: utilization persists despite the boxed warning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Duration of treatment with nonsteroidal anti-inflammatory drugs and impact on risk of death and recurrent myocardial infarction in patients with prior myocardial infarction: a nationwide cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Ibuprofen - a Safe Analgesic During Cardiac Surgery Recovery? A Randomized Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Multimodal analgesia versus traditional opiate based analgesia after cardiac surgery, a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Does the use of non-steroidal anti-inflammatory drugs after cardiac surgery increase the risk of renal failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

NSAID-analgesia, pain control and morbidity in cardiothoracic surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Opioid-sparing effects of diclofenac and paracetamol lead to improved outcomes after cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Postoperative naproxen after coronary artery bypass surgery: a double-blind randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Black box warning: is ketorolac safe for use after cardiac surgery?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Postoperative analgesia with ketorolac is associated with decreased mortality after isolated coronary artery bypass graft surgery in patients already receiving aspirin: a propensity-matched study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Perioperative gabapentin for the prevention of persistent pain after thoracotomy: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Impact of pregabalin on acute and persistent postoperative pain: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Ketamine spares morphine consumption after transthoracic lung and heart surgery without adverse hemodynamic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Is there a role for gabapentin in preventing or treating pain following thoracic surgery?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Comparison of S-(+)-ketamine- with sufentanil-based anaesthesia for elective coronary artery bypass graft surgery: effect on troponin T levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Morphine with adjuvant ketamine vs higher dose of morphine alone for immediate postthoracotomy analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Inadequate blood glucose control is associated with in-hospital mortality and morbidity in diabetic and nondiabetic patients undergoing cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Intensive insulin therapy in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

The effect of tight glycaemic control, during and after cardiac surgery, on patient mortality and morbidity: A systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Effects of intensive glycemic control on outcomes of cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Elevated preoperative hemoglobin A1c level is predictive of adverse events after coronary artery bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Tight glycemic control in acutely ill patients: low evidence of benefit, high evidence of harm!

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Superiority of moderate control of hyperglycemia to tight control in patients undergoing coronary artery bypass grafting

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Strict versus liberal target range for perioperative glucose in patients undergoing coronary artery bypass grafting: a prospective randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Randomized Controlled Trial of Intensive Versus Conservative Glucose Control in Patients Undergoing Coronary Artery Bypass Graft Surgery: GLUCO-CABG Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Intensive versus conventional glucose control in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Perioperative hyperglycemia and risk of adverse events among patients with and without diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Diabetes and the Association of Postoperative Hyperglycemia With Clinical and Economic Outcomes in Cardiac Surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

A comparison of inpatient glucose management guidelines: implications for patient safety and quality

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Intensive intraoperative insulin therapy versus conventional insulin therapy during cardiac surgery: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Timing, Predictive Factors, and Prognostic Value of Cerebrovascular Events in a Large Cohort of Patients Undergoing Transcatheter Aortic Valve Implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZX314

Preoperative statin therapy for patients undergoing cardiac surgery

21 January 2018

1 reference

COCI

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD008493.PUB3

9 February 2024

Identifiers

DOI

10.1093/EJCTS/EZX314

1 reference

24 February 2018

PubMed ID

29029110

1 reference

24 February 2018